Javascript must be enabled to continue!
1560 Sessile Serrated Polyposis Syndrome (SPS) and Sessile Serrated Polyps (SSPs): Features, Variations in Detection Rate, and the Associated Risk of Both Synchronous and Metachronous Neoplasia
View through CrossRef
INTRODUCTION:
Colorectal cancer (CRC) is the second most common cancer worldwide, accounting for 8% of all cancer related deaths. Sessile serrated polyposis syndrome (SPS) is a genetically inherited disease. The actual prevalence is unknown but is estimated to be 1 in 2000 to 3000
CASE DESCRIPTION/METHODS:
63 year old female with no family history of colon cancer, presented for a diagnostic colonoscopy after a positive fecal occult blood test (FOBT). FOBT was done for screening purposes. Patient had a negative FOBT X 3 a year ago. Colonoscopy showed 10 polyps. All polyps were resected with different techniques based on size, features and location. All polyps came back as sessile serrated polyps. 6 polyps showed features of cytologic dysplasia. 5 were proximal to the Sigmoid colon (1 was >20 mm in size and 3 were >10 mm in size).
DISCUSSION:
Based on a growing body of data, sessile serrated polyps (SSPs) have a higher prevalence than previously thought. Whether sporadic or part of the sessile serrated polyposis syndrome (SPS), SSPs are associated with increased risk of synchronous and metachronous neoplasia. A recent study looked at the synchronous burden of large (≥ 20 mm) SSPs in patients without SPS. The study found that 67/146 patients (45.9 %) had SPS, 53/146 (36.3 %) had a solitary SSP, and 26/146 (17.8 %) were categorized as oligo-SSP. Dysplasia in large SSPs was frequent in all groups (41.1 % overall). SPS was recognized by referring endoscopists in only 9.0 % of cases. Patients meeting the World Health Organization criteria who elect long-term endoscopic surveillance should receive annual colonoscopy after the diagnosis is established. Surgery is indicated when CRC is diagnosed or the number of polyps makes endoscopic control unfeasible. White-light endoscopy is considered the gold standard for detection and removal of colorectal lesions to prevent CRC development. However, detection of small adenomas (<5 mm) and SSPs is difficult as conventional endoscopy relies on the experience of the endoscopist. As a result, the reported adenoma detection miss rate for the general population is relatively high (27%). This underscores the necessity of improving endoscopic detection strategies. In a randomized controlled trial, 86 patients with SPS underwent tandem high-definition (HD) colonoscopies from February 2015 through July 2016 at 7 centers in Spain. It was found that panchromoendoscopy increases detection of polyps (mostly of small serrated lesions) and should be considered in patients with SPS.
Ovid Technologies (Wolters Kluwer Health)
Title: 1560 Sessile Serrated Polyposis Syndrome (SPS) and Sessile Serrated Polyps (SSPs): Features, Variations in Detection Rate, and the Associated Risk of Both Synchronous and Metachronous Neoplasia
Description:
INTRODUCTION:
Colorectal cancer (CRC) is the second most common cancer worldwide, accounting for 8% of all cancer related deaths.
Sessile serrated polyposis syndrome (SPS) is a genetically inherited disease.
The actual prevalence is unknown but is estimated to be 1 in 2000 to 3000
CASE DESCRIPTION/METHODS:
63 year old female with no family history of colon cancer, presented for a diagnostic colonoscopy after a positive fecal occult blood test (FOBT).
FOBT was done for screening purposes.
Patient had a negative FOBT X 3 a year ago.
Colonoscopy showed 10 polyps.
All polyps were resected with different techniques based on size, features and location.
All polyps came back as sessile serrated polyps.
6 polyps showed features of cytologic dysplasia.
5 were proximal to the Sigmoid colon (1 was >20 mm in size and 3 were >10 mm in size).
DISCUSSION:
Based on a growing body of data, sessile serrated polyps (SSPs) have a higher prevalence than previously thought.
Whether sporadic or part of the sessile serrated polyposis syndrome (SPS), SSPs are associated with increased risk of synchronous and metachronous neoplasia.
A recent study looked at the synchronous burden of large (≥ 20 mm) SSPs in patients without SPS.
The study found that 67/146 patients (45.
9 %) had SPS, 53/146 (36.
3 %) had a solitary SSP, and 26/146 (17.
8 %) were categorized as oligo-SSP.
Dysplasia in large SSPs was frequent in all groups (41.
1 % overall).
SPS was recognized by referring endoscopists in only 9.
0 % of cases.
Patients meeting the World Health Organization criteria who elect long-term endoscopic surveillance should receive annual colonoscopy after the diagnosis is established.
Surgery is indicated when CRC is diagnosed or the number of polyps makes endoscopic control unfeasible.
White-light endoscopy is considered the gold standard for detection and removal of colorectal lesions to prevent CRC development.
However, detection of small adenomas (<5 mm) and SSPs is difficult as conventional endoscopy relies on the experience of the endoscopist.
As a result, the reported adenoma detection miss rate for the general population is relatively high (27%).
This underscores the necessity of improving endoscopic detection strategies.
In a randomized controlled trial, 86 patients with SPS underwent tandem high-definition (HD) colonoscopies from February 2015 through July 2016 at 7 centers in Spain.
It was found that panchromoendoscopy increases detection of polyps (mostly of small serrated lesions) and should be considered in patients with SPS.
Related Results
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Abstract
Introduction: Granulomatous mastitis (GM) is a rare inflammatory breast disease that mimics carcinoma. GM can coexist with breast cancer (BC), though the relationship rema...
Endoscopic Surveillance in Serrated Polyposis Syndrome: Two or Three-Year Intervals. A Noninferiority Randomized Trial
Endoscopic Surveillance in Serrated Polyposis Syndrome: Two or Three-Year Intervals. A Noninferiority Randomized Trial
Abstract
Background:
Serrated polyposis syndrome, the most prevalent colonic polyposis, confers an increased colorectal cancer ...
Abstract 1448: Unraveling the oncogenic pathway of serrated polyposis syndrome driven by RNF43 germline mutation
Abstract 1448: Unraveling the oncogenic pathway of serrated polyposis syndrome driven by RNF43 germline mutation
Abstract
Serrated polyps can arise in a sporadic or familial polyposis setting and predispose to colorectal cancer (CRC). Recently, we have identified RNF43 germline...
P0445 High risk of colorectal cancer after high-grade dysplasia in Inflammatory Bowel Disease patients
P0445 High risk of colorectal cancer after high-grade dysplasia in Inflammatory Bowel Disease patients
Abstract
Background
Colonic high-grade dysplasia (HGD) is the highest-risk precursor of colorectal cancer (CRC) in inflammatory ...
P307 Colorectal neoplasia risk in patients with inflammatory bowel disease and serrated lesions
P307 Colorectal neoplasia risk in patients with inflammatory bowel disease and serrated lesions
Abstract
Background
The presence of serrated lesions (SLs) is an established risk factor for colorectal neoplasia development in...
The “Studded” Rectum: Phenotypic Evidence of MYH-Associated Polyposis
The “Studded” Rectum: Phenotypic Evidence of MYH-Associated Polyposis
BACKGROUND:
MYH-associated polyposis is a recessively inherited syndrome of colorectal cancer predisposition attributed to biallelic g...
G-EYE Colonoscopy Is Superior to Standard Colonoscopy for Increasing Adenoma/Polyp Detection Rate
G-EYE Colonoscopy Is Superior to Standard Colonoscopy for Increasing Adenoma/Polyp Detection Rate
Abstract
Background
Colorectal cancer (CRC) is one of the most common cancers worldwide. Most CRCs develop from malignant potent...
1527 Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome
1527 Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome
INTRODUCTION:
Ulcerative colitis (UC) is associated with increased risk of colon cancer. Current knowledge of UC with concomitant serrated polyposis syndrome (SPS) is l...

